AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Abiraterone Acetate USP
8 registrations across 3 African markets— 8 active
Markets with Abiraterone Acetate USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Abirannova oral tablets kit | 🇿🇲Zambia | Innovata Pharmaceuticals (Pty) Ltd | active | Aug 2030 |
| ABIRAT 250 Tablets+ Filmcoated | 🇿🇲Zambia | Hetero Labs Limited | active | Aug 2030 |
| ABERONE 500 Film-Coated Tablet | 🇰🇪Kenya | WIN-PHARMA LTD | active | Mar 2030 |
| ABERONE 250 Tablet | 🇰🇪Kenya | WIN-PHARMA LIMITED | active | Oct 2029 |
| ABIRAT 500 Tablets | 🇷🇼Rwanda | M/S HETERO LABS LIMITED, UNIT V | active | Aug 2029 |
| ZABITERON-250 Tablets | 🇷🇼Rwanda | ZUVIUS LIFESCIENCES PVT. LTD. | active | Aug 2029 |
| ABEECARE 500 Film-Coated Tablet | 🇰🇪Kenya | Javia International Limited | active | Aug 2028 |
| BIRATO 250 Tablet | 🇰🇪Kenya | MSN Laboratories Private Limited | active | Aug 2026 |
Abiraterone Acetate USP in Africa — Regulatory Overview
Abiraterone Acetate USP is registered across 3 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Rwanda, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 8 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.